Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Cerebras’s hosted Qwen3 Coder service promised to be the Claude replacement many developers craved. We’re losing hope.

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

David Duchovny is known to audiences for his iconic roles in "Californication" and "The X-Files." He's now turning his attention to something more intimate: poems that wrestle with love, loss, memory ...

The Athletic has live coverage of the U.S. Open men’s final featuring Jannik Sinner vs. Carlos Alcaraz FLUSHING, N.Y. — The last time Aryna Sabalenka stood in front of a microphone after losing a ...

Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

Vertex Minerals (ASX:VTX) is still in the early stages of developing its underground mine, and while the production ramp-up was slowed by delays in high-voltage equipment delivery and commissioning, ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

When OpenAI announced the release of GPT-5 this month, the company boasted about how it could supposedly produce “resonant writing with literary depth and rhythm.” In a lengthy post on his personal ...